StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) stock

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)

Close on Nov 17, 2026Market cap $110.08MP/E –Yield –

Journey Medical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Journey Medical's pe ratio was 135.5× on Oct 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 2024135.5×–

More Journey Medical figures

See a number that looks wrong?